With $250 million, Peter Diamandisâ new startup is all about taking stem cells from placentas
Stem cells derived from a human placenta hold the key to unlocking a myriad of potentials in regenerative medicine and are the focus of X-Prize and Singularity University founder Peter Diamandis’ new endeavor. Called Celularity, the startup is a spinout from Celgene, a global biopharmaceutical company creating gene therapies. Diamandis teamed up with Dr. Robert Hariri, the founder of… Read More
Sign in to read full story
In order for you to continue reading the full contents of the post, you will need to login first
